RE:AKRO ‘s market cap up 400 million$ on Nash Results$400 million market cap for hope that their NASH drug will be successful. There is good reason to hope but it would have been nice if at some point along the way THTX would have been able to generate a little hope in Egrifta in NASH, especially during the bubble, so that THTX's price could have behaved somewhat similarly to the other similar stocks.
Until Egrifta in NASH becomes something via a partnership, it is not going to get any credit from investors.
On to cancer and TH-1902!